Yes. A foreign facility’s registration must designate a U.S. Agent. The U.S. Agent may register the facility but is not required to. FDA describes the U.S. Agent as the communications link with FDA.
A foreign facility that must register must designate a U.S. Agent. Under 21 CFR 1.227, the U.S. Agent is the communications link between FDA and the foreign facility for emergency and routine communications. FDA treats information given to the agent as given to the facility.
No. They are separate FDA programs (FD&C Act § 607 / Cosmetics Direct vs FD&C Act § 415 / FURLS). One company can serve in both roles. One appointment does not cover both.
Starting at $299 per year per facility for cosmetics, dietary supplements, and food (including pet food). That is Axentra’s fee for appointment, facility registration, and FDA communications — not an FDA fee. Listing, labels, NDI, FSVP, Form 2541 process filing, OTC, drugs, and devices are quoted separately.